InvestorsHub Logo
Followers 828
Posts 119319
Boards Moderated 16
Alias Born 09/05/2002

Re: None

Monday, 11/23/2020 8:34:35 AM

Monday, November 23, 2020 8:34:35 AM

Post# of 866
MRK acquires—(private)—Oncoimmune for $425M cash plus contingent payments:

https://finance.yahoo.com/news/merck-acquire-oncoimmune-114500835.html

OncoImmune recently announced positive top-line findings from an interim efficacy analysis of a Phase 3 study evaluating its lead therapeutic candidate CD24Fc for the treatment of patients with severe and critical COVID-19.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News